The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Molipaxin 50mg Capsules

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/056/001

Main Information

Trade NameMolipaxin 50mg Capsules
Active SubstancesTrazodone hydrochloride
Dosage FormCapsule, hard
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/056/001

Group Information

ATC CodeN06AX Other antidepressants
N06AX05 trazodone


License statusAuthorised
Licence Issued02/02/1977
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back